FDA

On April 18, 2026, President Donald Trump signed an executive order intended to ease federal research restrictions on psychedelic drugs, explicitly naming ibogaine a...

The U.S. Food and Drug Administration posted a warning letter to ImmunityBio on March 25, 2026, stating that a television advertisement and a podcast appearance feat...

The article (an opinion piece) warns that certain medical devices used in U.S. hospitals—specifically patient monitors made by Contec Medical Systems, a Chinese firm...

Demand for hormone therapy to treat menopausal symptoms has risen in recent years, in part because the FDA removed a long-standing black-box warning on estrogen prod...

More than 100 Republican members of Congress filed an amicus brief with the U.S. Supreme Court supporting Louisiana’s lawsuit to reinstate an in-person dispensing re...

A three-judge panel of the U.S. Court of Appeals for the 5th Circuit issued a decision blocking mail-order distribution of mifepristone and reinstating a requirement...

On May 4, 2026, U.S. Supreme Court Justice Samuel Alito issued an administrative stay temporarily halting a U.S. Court of Appeals for the 5th Circuit order that had ...

On April 23, 2026 the U.S. Department of Justice, through Acting Attorney General Todd Blanche, issued an order placing FDA-approved drug products that contain marij...

This Fox News opinion piece argues the United States has become highly dependent on China for pharmaceuticals and their inputs, creating a national security and publ...

U.S. District Judge David C. Joseph (a Trump appointee) issued a 37-page ruling granting the Food and Drug Administration's request to stay a lawsuit filed by the st...

After a high-profile federal press conference that highlighted leucovorin (folinic acid) in the context of treating cerebral folate deficiency, many families of chil...

An FDA advisory committee convened for a two-day meeting to consider lifting a ban and widening access to seven peptides that have grown popular in wellness circles....